PR002195 (Project)

Description:Untargeted analysis of plasma from repeated samples from the USDoD in a study of Inflammatory Bowel Disease. Serum samples from 6-10 years, 4 years, 2 years, and within 1+- years of a Crohn's diagnoses, Ulcerative Colitis, or matched controls were analyzed with GC-HRMS. Associations between the chemical mixture and IBD were tested.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project

Biosample

A biosample from Metabolomics produced as part of the PR002195 project


  • Subject

    A subject from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002195 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.